Challenges in identifying and quantifying country-level participation in multi-country randomised controlled trials involving Ireland as a collaborating partner
View ORCID ProfileJames Larkin, Uchechukwu Alanza, Vikneswaran Raj Nagarajan, Maurice Collins, Sami Termanini, Emmet Farrington, Barbara Clyne, Tom Fahey, View ORCID ProfileFrank Moriarty
doi: https://doi.org/10.1101/2024.03.04.24303711
James Larkin
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
2School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Uchechukwu Alanza
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Vikneswaran Raj Nagarajan
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Maurice Collins
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Sami Termanini
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Emmet Farrington
2School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Barbara Clyne
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
3Department of Public Health and Epidemiology, School of Population Health, RCSI University
Tom Fahey
1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Frank Moriarty
2School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Article usage
Posted March 04, 2024.
Challenges in identifying and quantifying country-level participation in multi-country randomised controlled trials involving Ireland as a collaborating partner
James Larkin, Uchechukwu Alanza, Vikneswaran Raj Nagarajan, Maurice Collins, Sami Termanini, Emmet Farrington, Barbara Clyne, Tom Fahey, Frank Moriarty
medRxiv 2024.03.04.24303711; doi: https://doi.org/10.1101/2024.03.04.24303711
Challenges in identifying and quantifying country-level participation in multi-country randomised controlled trials involving Ireland as a collaborating partner
James Larkin, Uchechukwu Alanza, Vikneswaran Raj Nagarajan, Maurice Collins, Sami Termanini, Emmet Farrington, Barbara Clyne, Tom Fahey, Frank Moriarty
medRxiv 2024.03.04.24303711; doi: https://doi.org/10.1101/2024.03.04.24303711
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)